| Report ID | Date of report | Patient age | Patient gender |
| 144000 | Jun, 19, 2006 | Not specified | Female |
List of drugs the patient takes:
| Drug | Ingredient(s) |
Myleran | busulfan |
Fludarabine Phosphate | fludarabine phosphate |
Cyclosporine | cyclosporine |
| Name |
Aplasia |
Graft Versus Host Disease In Skin |
Neutrophil Count Abnormal |
Platelet Count Decreased |
Sepsis |
Results from eHealthMe : 305 report(s)Comparison with the patient:
| Name | Count (% of total reports) |
Aplasia | 3 (0.98%) |
Graft Versus Host Disease In Skin | 3 (0.98%) |
Neutrophil Count Abnormal | 2 (0.66%) |
Platelet Count Decreased | 86 (28.20%) |
Sepsis | 33 (10.82%) |
Top 3 (total: 102. Click here to see more) co-used drugs - potential interacting drugs:
| Name | Count (% of total co-drugs) |
Neoral | 1183 (30.70%) |
Sandimmune | 199 (5.16%) |
Diflucan | 152 (3.94%) |
Death reported: 0
| Name | Count (% of total reports) |
Graft Versus Host Disease | 135 (44.26%) |
Platelet Count Decreased | 86 (28.20%) |
Cytomegalovirus Antigen Positive | 78 (25.57%) |
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Recent drug risk analysis reports:
|
|
Don't find what you want? We have customized services for patients, professionals, and clinics. Let us know (click here) and see whether we can help.
| |
